Navigation Links
Therapeutic vaccines

This release is available in German.

SARS, avian flu, Ebola outbreaks of deadly viral infections are becoming increasingly frequent. And we still don't have vaccines for many of the pathogens responsible. One of the most dangerous classes of viral diseases is the zoonosis, which can be transmitted from animals to humans with sometimes fatal consequences. One of these is caused by the West Nile virus (WNV), which was first identified in Uganda in 1937. The virus was carried to the United States in 1999 and had spread through the whole of North America within five years. There is now a risk that it will propagate worldwide. Since its first appearance in the United States, around 400 people have died there after coming into contact with the West Nile virus. A new vaccine promises to provide protection.

Scientists at the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig have developed the DNA vaccine. "In this type of vaccine, DNA molecules known as plasmids extracted from the pathogen are used for inoculation, instead of the whole virus. They contain the genetic code for the antigens that stimulate the body to produce antibodies. We can thus replicate the virus's natural infection route without actually triggering the disease," explains Dr. Matthias Giese, the IZI's head of vaccine development. Conventional methods of vaccination involve injecting a dead or weakened form of the pathogen into the patient's body, which responds by producing the corresponding antibodies and developing immunity to the disease. An alternative is to inject a serum that already contains these antibodies. Such vaccines are merely preventive. By contrast with live vaccines, which carry a risk of provoking the disease, DNA vaccines are absolutely biologically safe. Moreover, they activate all existing defense mechanisms in the body, are cheap to produce and can be stored without a refrigerator which makes them ideal for use in subtropical and tropical climates.

"Since the human immune system is very similar to that of other mammals, we are developing a cross-species vaccine for use in both veterinary and human medicine. And unlike conventional vaccines, DNA vaccines can be used both as prophylactics and as therapeutics, i.e. in cases where the disease is already present," says Dr. Matthias Giese, citing the further benefits. The WNV vaccine has already passed initial tests. Giese expects the laboratory research to be completed by the end of 2009. After that, another 3 years or so will be needed for the approval procedure including clinical trials. Then, it is hoped, the world's first therapeutic WNV vaccine will be ready for market.


Contact: Dr. Matthias Giese

Related medicine news :

1. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
2. Prime Therapeutics Receives TIPPS Certification
3. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
4. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
8. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
9. Prime Therapeutics Announces URAC Accreditation
10. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
11. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Though trick-or-treating remains ... confines of their home. Whether it's making fun pre or post trick-or-treat snacks ... Florida Dairy Farmers. , Recipe 1: Green Chile Queso Dip with Sriacha ...
(Date:10/13/2015)... ... (PRWEB) ... (MOAA) will hold its 2015 annual meeting and corresponding events ... career fair; informational seminars; a luncheon featuring keynote speaker Air ... of Staff; and the Community Heroes Award Night, which recognizes ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... new Pillars of Excellence in the Life Sciences Initiative aimed at enhancing Purdue’s ... recently announced $2 billion “Ever True” capital campaign. , The investment will result ...
(Date:10/13/2015)... ... 13, 2015 , ... Sir Grout of Greater Boston donated an expansive, seven ... Ronald McDonald House Charities® (RMHC®). This donation was made in an effort to give ... since its inception. , “We believe strongly in the Ronald McDonald House Charities, and ...
(Date:10/13/2015)... ... 13, 2015 , ... Califia Farms , one of ... release of its limited edition holiday seasonal flavors: Almondmilk Holiday Nog, new Peppermint ... unique flavor combinations and delicious taste Califia Farms’ beverages are known for, without ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 13, 2015   Generational Equity , a leading ... pleased to announce the acquisition of its client, ... Largo, Florida , by Meridian Biomedical, Inc. (Meridian), ... 2015. Florida . To ... Florida . To learn more, visit ...
(Date:10/13/2015)...  Kay Elledge, M.D., an established South Bay ... Obstetrics and Gynecology (FACOG) for the past 21 ... Self Medical Laser Center where she provides laser ... Breast Cancer Awareness Month , the Center ... Touch treatments initiated in the month of ...
(Date:10/13/2015)... 2015 According to the 2015 ... by Cardinal Health , achieving both higher ... pharmacy revenue streams are vital to the future ... NCPA Digest affirms that independent community pharmacies ... underserved inner city and rural areas," said NCPA ...
Breaking Medicine Technology: